Volume 9 Supplement 1
Proceedings of 18th Pediatric Rheumatology European Society (PReS) Congress
Meeting abstracts
Edited by Rolando Cimaz, Pavla Dolezalova, Marco Gattorno, Hermann Girschick, Michael Hofer, Sue Maillard, Alberto Martini, Pierre Quartier, Carlos Rose, Johannes Roth, Rebecca ten Cate and Carine Wouters.
18th Pediatric Rheumatology European Society (PReS) Congress. Go to conference site.
Bruges, Belgium14-18 September 2011
Page 6 of 8
-
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P208
-
Evaluation of disease activity in a population of Russian JIA patients
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P209 -
Chronic exposure to Interleukin-6 amplifies the response to Toll-like receptor ligands: implication on the pathogenesis of macrophage activation syndrome
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P210 -
Fulminate mycoplasma infection and severe cutaneous vasculitis: an unusual presentation of complete MBL deficiency
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P211 -
Acceptability and practicality of pGALS musculoskeletal screening tool in Malawian children
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P212 -
A year in the life of the streptococcus
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P213 -
Involvement of the heart in Kawasaki Disease: not always coronaritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P214 -
CACP syndrome (Camptodactyly Arthropathy Coxa Vara Pericarditis). Clinical case
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P215 -
Inflammatory lesions of the orbit: a single paediatric rheumatology centre experience
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P216 -
Artherial thrombosis with antiphospholipid syndrome in 17 year old female patient: case of familial antiphospholipid syndrome
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P217 -
Risk of latent tuberculosis in at-risk children with rheumatic diseases
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P218 -
Infliximab in the treatment of refractory uveitis. Does dose really matter?
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P219 -
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P220 -
The Guadalajara-Camptodactyly Syndrome-an unusual case
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P221 -
Suptypes of JIA have different susceptibility for developing pain amplification syndrome
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P222 -
Epidemiology of uveitis in children over a 10 years period
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P223 -
A case of pachydermodactyly in a 16 year-old male
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P224 -
Are growing pains a parasomnia?
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P225 -
Lethal chickenpox infection during treatment with infliximab and methotrexate
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P226 -
Current evidence of MTX efficacy in childhood chronic uveitis: a systematic review and meta-analysis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P227 -
Familial hypercholesterolemia misinterpreted as juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P228 -
Autoantibodies frequency in children with visceral leishmaniosis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P229 -
Antinuclear antibodies (ANA) in a Colombian cohort of pediatric patients with autoimmune diseases (PAID)
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P230 -
Chronic destructive arthritis as an isolated symptom of familial Mediterranean fever (FMF) in a 17 year old Turkish boy
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P231 -
Manifestation of connective tissue diseases (CTD) in pediatrics patients with autoimmune hepatitis (AIH)
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P232 -
Septic sacroiliitis in children-a diagnostic challenge
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P233 -
Raynaud's phenomenon in pediatric age
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P234 -
Various aspects of Kikuchi disease in three children: systemic or self-limited disease?
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P235 -
Predictive clinical and hematological factors in the differential diagnosis between malignancy and arthritis in children: a case-control study
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P236 -
Reports to the UK Yellow Card Scheme 2000-2009 for medications used in paediatric rheumatology
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P237 -
Complementary and alternative medicine (CAM) in pediatric rheumatology: an European perspective
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P238 -
Etoposide in patients with rheuma-associated hemophagocytic lymphohistiocytosis / macrophage activation syndrome
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P239 -
Evaluation of hypermobility syndrome associated with vesico-ureteric reflux in children
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P240 -
Systemic Lupus Erythematosus complicated by Neuromyelitis Optica (Devic’s Syndrome): case series from a single paediatric rheumatology centre
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P241 -
Hematological features in children with systemic lupus erythematosus: are they more common than appreciated?
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P242 -
Health related quality of life in juvenile SLE patients– use of the PedsQL 3.0 rheumatology module
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P243 -
FDG-PET in juvenile systemic lupus erythematosus
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P244 -
A Greek multicenter study comparing the clinical and immunologic phenotypes between adult and juvenile- onset lupus
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P245 -
Safety and efficacy of rituximab in refractory pediatric Systemic Lupus Erythematosus nephritis: a single-center experience of northern Greece
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P246 -
Achieving consensus on quality indicators (QI) for pediatric Systemic Lupus Erythematosus (pSLE)
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P247 -
Is there any relationship between the exposure to mycophenolic acid and the clinical status in children with lupus?
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P248 -
A case of generalized psoriasis-like skin lesions caused by rituximab use in a 14-years patient with systemic lupus erythematosus
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P249 -
Two different cases of SLE with neuropsychiatric manifestation
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P250 -
Cross-sectional evaluation of bone mass in young adults with Juvenile Onset Systemic Lupus Erythematosus: the role of bone mass determinants in a large cohort of patients
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P251 -
Acute adrenal failure (AAF) as the presenting symptom of primary antiphospholipid syndrome (APS)
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P252 -
Bone mineral density in patients with juvenile systemic lupus erythematosus
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P253 -
Liver involvement in juvenile systemic lupus erythematosus (SLE)
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P254 -
The role of kidney biopsy in a patient with juvenile SLE with no urine abnormity or no signs of renal failure
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P255 -
Penile anthropometry in adolescents and adults systemic lupus erythematosus
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P256 -
Systemic lupus erythematosus in Saudi children: Long-term outcome
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P257
Official journal of
Annual Journal Metrics
-
Citation Impact
3.413 - 2-year Impact Factor (2021)
3.970 - 5-year Impact Factor (2021)
1.315 - Source Normalized Impact per Paper (SNIP)
1.051 - SCImago Journal Rank (SJR)Speed
54 days to first decision for all manuscripts (Median)
68 days to first decision for reviewed manuscripts only (Median)
Usage
901,346 Downloads (2022)
661 Altmetric mentions (2021)